1. Home
  2. TCRX vs VTSI Comparison

TCRX vs VTSI Comparison

Compare TCRX & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.03

Market Cap

64.1M

Sector

Health Care

ML Signal

HOLD

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.78

Market Cap

61.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
VTSI
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
64.1M
61.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TCRX
VTSI
Price
$1.03
$4.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$8.50
$7.00
AVG Volume (30 Days)
823.7K
56.4K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$8,423,000.00
$24,934,267.00
Revenue This Year
$286.83
N/A
Revenue Next Year
N/A
$13.39
P/E Ratio
N/A
$331.53
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$3.57
52 Week High
$3.43
$7.49

Technical Indicators

Market Signals
Indicator
TCRX
VTSI
Relative Strength Index (RSI) 39.94 35.80
Support Level $0.99 $4.79
Resistance Level $1.09 $5.13
Average True Range (ATR) 0.09 0.14
MACD 0.03 0.01
Stochastic Oscillator 35.71 7.55

Price Performance

Historical Comparison
TCRX
VTSI

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: